NCT00758940 is a Phase 4 clinical trial of Acrysof ReSTOR multifocal IOL in Visual Outcomes, sponsored by Alcon Research.

Who is sponsoring NCT00758940?

NCT00758940 is sponsored by Alcon Research.

What drugs are being tested in NCT00758940?

Interventions in NCT00758940: Acrysof ReSTOR multifocal IOL.

What condition does NCT00758940 study?

NCT00758940 studies Visual Outcomes.

Is NCT00758940 still recruiting?

NCT00758940 is currently withdrawn. Last updated 12 May 2015.

Last reviewed 2015-05-12 · How we verify

NCT00758940

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL

Withdrawn Phase 4 Last updated 12 May 2015

What this trial tests

Phase 4 trial testing Acrysof ReSTOR multifocal IOL in Visual Outcomes. Withdrawn.

Quick facts

Lead sponsor	Alcon Research
Phase	Phase 4
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Sites	1 location across United States

Drugs / interventions tested

Acrysof ReSTOR multifocal IOL

Conditions studied

Visual Outcomes — all drugs for Visual Outcomes →

Sponsor

Alcon Research — full company profile →

Who can join

21 and older, any sex, with Visual Outcomes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An unmasked trial after bilateral implantation of AcrySof® ReSTOR®, SA60D3 IOL . Enrolled are at least 30 patients or as much as possible from the doctor's clinical practice perspective. 6 months follow-up after IOL implant in the 2nd eye

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Alcon Research trials

Trials by the same sponsor.

NCT06884202 — Evaluation of Delefilcon A Contact Lenses · NA · completed
NCT06784063 — Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs) · NA · completed
NCT06571656 — Evaluation of the Safety and Tolerability of Ocular Lubricants · NA · terminated
NCT06660290 — A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes · Phase 3 · completed
NCT06483113 — DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00758940 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alcon Research
Last refreshed: 12 May 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00758940.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing